Atlas Trials

Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites

Clinical trial NCT03230708 · UNKNOWN

Trial details

NCT number
NCT03230708
Sponsor
Hui ting Xu,MD
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Ascites
Start date
2017-05-01
Primary completion
2017-12-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.